Treating Amblyopia (Lazy Eye) with the world's most advanced clinically proven vision therapy software. Safe, effective, and done from home.
CureSee's AI engine tailors treatment to each patient's unique vision profile, no two programs are alike.
Lazy Eye, our primary focus. Clinically validated AI therapy.
Therapy for screen-induced eye strain and fatigue.
Visual rehabilitation following LASIK and similar procedures.
Guided adaptation therapy for scleral and specialty lens users.
Neuro-visual rehabilitation for brain-based vision loss.
Visual training to help patients make the most of their remaining field of vision.
From prescription to progress, our AI handles the complexity so doctors and patients don't have to.
Our clinical studies conducted by leading ophthalmologists demonstrated statistically significant improvements in Visual Acuity and Stereopsis, published in journals and presented at International Ophthalmology conferences such as World Ophthalmology Congress and All India Ophthalmology Conferences.
Journal of Optometry and Ophthalmology · 68 patients
AIOS 2024, FP1189 · 42 patients
3rd Mid Term AIOS 2024, FP0198 · 60 patients
Watch our founders pitch CureSee's AI vision therapy to the Sharks.
Doctors' reviews say more about our work than anything we could write about ourselves. Don't take our word for it; hear it from them.
“CureSee is incredible. It not only looks after my patients well, but it also ensures that they get the greatest outcomes possible.”
“A facility like CureSee is hard to find in the eyecare industry that combines exceptional quality eye care with personal touch and care for every patient.”
“CureSee Vision Therapy is really great in improving patient’s vision in difficult cases as well.”
“We have done many patients on CureSee Vision Therapy and saw exceptionally amazing results. Thank you CureSee”
Watch families and patients describe their vision journey in their own words.
Video player could not load.
Watch on YouTubeJoin 1,500+ clinics already using CureSee to offer world-class vision therapy to their patients.
